1998
DOI: 10.1016/s0001-2998(98)80018-4
|View full text |Cite
|
Sign up to set email alerts
|

Orthopedic pathology of the lower extremities: Scintigraphic evaluation in the thigh, knee, and leg

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2001
2001
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(15 citation statements)
references
References 85 publications
0
15
0
Order By: Relevance
“…Bone scintigraphy of the peripheral extremities is an excellent tool to detect orthopedic disorders [1][2][3][4][5][6][7][8][9][10][11][12][13][14][29][30][31]. However, the evidence on the value of hybrid imaging of the peripheral extremities is scarce.…”
Section: Discussionmentioning
confidence: 99%
“…Bone scintigraphy of the peripheral extremities is an excellent tool to detect orthopedic disorders [1][2][3][4][5][6][7][8][9][10][11][12][13][14][29][30][31]. However, the evidence on the value of hybrid imaging of the peripheral extremities is scarce.…”
Section: Discussionmentioning
confidence: 99%
“…Etchebehere et al noted that bone scans precede radiographic changes in osteonecrosis of the knee (Etchebehere et al 1998 ). Another established indication of SPECT/ CT is the assessment of osteochondritis dissecans (OCD) (Konala et al 2010 ).…”
Section: Cartilage and Osteochondral Lesionsmentioning
confidence: 99%
“…Etchebehere et al highlighted that in case of delayed healing of fractures, bone scans are able to differentiate between avascular and hypervascular non-unions and delayed unions (Etchebehere et al 1998 ). They further noted that SPECT accurately detects decreased metabolism associated with posttraumatic closure of the physeal plate, which could then lead to growth arrest and leg deformities.…”
Section: Shin Splint Syndrome Fractures Pseudoarthrosis and Osteonementioning
confidence: 99%
“…Various radiopharmaceuticals have been described in the literature under development in animals to allow imaging of cartilage as well as bone (Yu, Bartlett et al 1988;Yu, Shaw et al 1999). Other radiopharmaceuticals that target inflammation, osteophytes, cysts and sclerosis have also been described in a limited setting in the literature (Merrick 1992;Etchebehere, Etchebehere et al 1998). In positron emission spectroscopy (PET), 18-fluorodeoxyglucose (18-FDG) acts as a glucose analogue, taken up in cells within the body which have high glucose requirements.…”
Section: Bone Scansmentioning
confidence: 99%